Wantage, United Kingdom

James Macfarlane Gardiner

This inventor holds 1 USPTO granted patent. Top assignee: Exxon Chemical Patents, Inc.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of James Macfarlane Gardiner

Introduction

James Macfarlane Gardiner is a notable inventor based in Wantage, GB. He has made significant contributions to the field of chemical engineering, particularly in the area of olefin copolymers. His innovative approach has led to advancements that are beneficial for various industrial applications.

Latest Patents

One of Gardiner's key patents is titled "Molecular weight reduction of olefin copolymers using low-sulfur oils." This patent describes a method for reducing the molecular weight of olefin copolymers by contacting them with a base oil that contains less than about 0.05 wt. % sulfur, in the presence of oxygen and at a temperature of at least about 60°C. This innovative method has the potential to enhance the performance and efficiency of olefin copolymers in various applications.

Career Highlights

James Macfarlane Gardiner is associated with Exxon Chemical Patents, Inc., where he has been instrumental in developing new technologies and processes. His work has not only contributed to the company's portfolio but has also advanced the field of polymer chemistry.

Collaborations

Throughout his career, Gardiner has collaborated with notable professionals in the industry, including Keith James Fenner and Ralph J Spohn. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

James Macfarlane Gardiner's contributions to the field of chemical engineering and his innovative patent on olefin copolymers highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…